Canagliflozin and Cardiovascular and Renal Events in Type 2 DiabetesBruce Neal, David R. Matthews, Dick de Zeeuw et al.|New England Journal of Medicine|2017Cited by 7.7k
Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trialsVlado Perkovic, Bruce Neal, Kenneth W. Mahaffey et al.|The Lancet Diabetes & Endocrinology|2018Cited by 642